Cargando…
Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2
BACKGROUND: Diabetic cardiomyopathy (DCM) is a cardiac complication of long-term uncontrolled diabetes and is characterized by myocardial fibrosis and abnormal cardiac function. Mesenchymal stem cells (MSCs) are multipotent cells with immunoregulatory and secretory functions in diabetes and heart di...
Autores principales: | Jin, Liyuan, Zhang, Jinying, Deng, Zihui, Liu, Jiejie, Han, Weidong, Chen, Guanghui, Si, Yiling, Ye, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079514/ https://www.ncbi.nlm.nih.gov/pubmed/32183879 http://dx.doi.org/10.1186/s13287-020-01633-7 |
Ejemplares similares
-
Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy
por: Jin, Liyuan, et al.
Publicado: (2019) -
Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity
por: Si, Yiling, et al.
Publicado: (2012) -
Mesenchymal stem cell-secreted prostaglandin E(2) ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarization
por: Wang, Jinglin, et al.
Publicado: (2021) -
The severity of NEC is ameliorated by prostaglandin E2 through regulating intestinal microcirculation
por: Mo, Dandan, et al.
Publicado: (2023) -
Sex differences in atrial remodeling and its relationship with myocardial fibrosis in hypertrophic obstructive cardiomyopathy
por: Bi, Xuanye, et al.
Publicado: (2022)